Literature DB >> 24792719

Melatonin: functions and ligands.

Mahaveer Singh1, Hemant R Jadhav2.   

Abstract

Melatonin is a chronobiotic substance that acts as synchronizer by stabilizing bodily rhythms. Its synthesis occurs in various locations throughout the body, including the pineal gland, skin, lymphocytes and gastrointestinal tract (GIT). Its synthesis and secretion is controlled by light and dark conditions, whereby light decreases and darkness increases its production. Thus, melatonin is also known as the 'hormone of darkness'. Melatonin and analogs that bind to the melatonin receptors are important because of their role in the management of depression, insomnia, epilepsy, Alzheimer's disease (AD), diabetes, obesity, alopecia, migraine, cancer, and immune and cardiac disorders. In this review, we discuss the mechanism of action of melatonin in these disorders, which could aid in the design of novel melatonin receptor ligands.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792719     DOI: 10.1016/j.drudis.2014.04.014

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  48 in total

1.  Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates.

Authors:  Alejandro Ibáñez-Costa; José Córdoba-Chacón; Manuel D Gahete; Rhonda D Kineman; Justo P Castaño; Raúl M Luque
Journal:  Endocrinology       Date:  2014-12-29       Impact factor: 4.736

Review 2.  Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions.

Authors:  Andrzej T Slominski; Ruediger Hardeland; Michal A Zmijewski; Radomir M Slominski; Russel J Reiter; Ralf Paus
Journal:  J Invest Dermatol       Date:  2018-02-07       Impact factor: 8.551

3.  The role of melatonin and cortisol circadian rhythms in the pathogenesis of infantile colic.

Authors:  Tolga İnce; Hakkı Akman; Dilek Çimrin; Adem Aydın
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

4.  Melatonin promoted renal regeneration in folic acid-induced acute kidney injury via inhibiting nucleocytoplasmic translocation of HMGB1 in tubular epithelial cells.

Authors:  Fengming Zhu; Octavia Ls Chong Lee Shin; Huzi Xu; Zhi Zhao; Guangchang Pei; Zhizhi Hu; Juan Yang; Yanchao Guo; Jingyi Mou; Jie Sun; Han Zhu; Yuxi Wang; Meng Wang; Qian Yang; Wenhui Liao; Gang Xu; Rui Zeng; Ying Yao
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 5.  A new balancing act: The many roles of melatonin and serotonin in plant growth and development.

Authors:  Lauren A E Erland; Susan J Murch; Russel J Reiter; Praveen K Saxena
Journal:  Plant Signal Behav       Date:  2015

Review 6.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

7.  Oral Administration of Melatonin or Succinyl Melatonin Niosome Gel Benefits 5-FU-Induced Small Intestinal Mucositis Treatment in Mice.

Authors:  Prangtip Uthaiwat; Aroonsri Priprem; Sirinart Chio-Srichan; Chatri Settasatian; Yao-Chang Lee; Pramote Mahakunakorn; Patcharee Boonsiri; Chanvit Leelayuwat; Patcharaporn Tippayawat; Ploenthip Puthongking; Jureerut Daduang
Journal:  AAPS PharmSciTech       Date:  2021-07-01       Impact factor: 3.246

8.  Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.

Authors:  Richard E Kast
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13

9.  Expression of the MT1 melatonin receptor in ovarian cancer cells.

Authors:  Karolina Jablonska; Bartosz Pula; Agata Zemla; Christopher Kobierzycki; Witold Kedzia; Ewa Nowak-Markwitz; Marek Spaczynski; Maciej Zabel; Marzenna Podhorska-Okolow; Piotr Dziegiel
Journal:  Int J Mol Sci       Date:  2014-12-12       Impact factor: 5.923

Review 10.  Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.

Authors:  Domenico De Berardis; Michele Fornaro; Nicola Serroni; Daniela Campanella; Gabriella Rapini; Luigi Olivieri; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Andrea De Bartolomeis; Alessandro Valchera; Giampaolo Perna; Monica Mazza; Marco Di Nicola; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.